Rabbit Recombinant Monoclonal Phosphotyrosine antibody. Suitable for IP, ChIP, Flow Cyt, ELISA, WB, IHC-P, ICC/IF and reacts with Modified Amino Acid samples. Cited in 2 publications. Immunogen corresponding to Chemical / Small Molecule corresponding to Phosphotyrosine.
Preservative: 0.09% Sodium azide
Constituents: 50% Glycerol (glycerin, glycerine), 48% PBS, 1% BSA
IP | ChIP | Flow Cyt | ELISA | WB | IHC-P | ICC/IF | |
---|---|---|---|---|---|---|---|
Modified Amino Acid | Tested | Expected | Expected | Tested | Tested | Expected | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Modified Amino Acid | Dilution info 1/200.00000 - 1/1000.00000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Modified Amino Acid | Dilution info 1/200.00000 - 1/1000.00000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Modified Amino Acid | Dilution info - | Notes ab172730 - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody. |
Species | Dilution info | Notes |
---|---|---|
Species Modified Amino Acid | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Modified Amino Acid | Dilution info 1/1000.00000 - 1/5000.00000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Modified Amino Acid | Dilution info 1/200.00000 - 1/500.00000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Modified Amino Acid | Dilution info 1/200.00000 - 1/500.00000 | Notes - |
Select an associated product type
L-Phosphotyrosine, L-Tyrosine-O-phosphate, O-Phospho-L-tyrosine, O-Phosphotyrosine, Phospho-L-tyrosine, Phosphonotyrosine
Rabbit Recombinant Monoclonal Phosphotyrosine antibody. Suitable for IP, ChIP, Flow Cyt, ELISA, WB, IHC-P, ICC/IF and reacts with Modified Amino Acid samples. Cited in 2 publications. Immunogen corresponding to Chemical / Small Molecule corresponding to Phosphotyrosine.
Preservative: 0.09% Sodium azide
Constituents: 50% Glycerol (glycerin, glycerine), 48% PBS, 1% BSA
This antibody reacts to tyrosine-phosphorylated proteins. No cross reactivity with non phosphorylated tyrosine, phospho-serine, and phospho-threonine
Purified from an animal origin–free culture supernatant.
Phosphotyrosine also known simply as pY is a post-translational modification where a phosphate group binds to the hydroxyl group of a tyrosine amino acid in proteins. This small modification can have a huge impact on proteins' function and interaction. Phosphotyrosine has a molecular weight of approximately 216 Da when it stands on its own. This modification can occur in various proteins expressed widely across tissues playing a role in signaling cell division and morphological changes.
Phosphorylated tyrosine residues modify the function and activity of proteins within cells. It is a critical component of signal transduction pathways and can alter protein functions when becoming part of large protein complexes. It often regulates receptor proteins and intracellular kinases modifying their ability to interact with other proteins like SH2 and PTB domain-containing proteins. Phosphotyrosine antibodies like anti-phosphotyrosine Ig2 are helpful research tools for detecting these modifications.
The modification of tyrosine to phosphotyrosine participates significantly in pathways such as the MAPK/ERK pathway and the PI3K/AKT pathway. These pathways are important for various cellular processes including growth and survival. Proteins like EGFR and PDGFR regulate signaling cascades by phosphorylation of tyrosine residues and often interact with phosphotyrosine and phosphotyrosine antibodies importantly.
The dysregulation of phosphotyrosine levels contributes to conditions like cancer and diabetes. Aberrant activation or overexpression of phosphotyrosine residues on receptors like HER2 and insulin receptors can promote uncontrolled cell proliferation often seen in tumors and contribute to insulin resistance respectively. As such phosphotyrosine serves not only as a biological target but also as a potential therapeutic target in the treatment of these disorders.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Immunoprecipitation of EGF-treated A431 cells pulling down Phosphotyrosine-EGFR by ab190824 at 1/1000 dilution; this was followed by western blot with an anti-EGFR rabbit monoclonal antibody.
(1) Whole lysate control;
(2) IP by rabbit IgG control;
(3) IP by ab190824
All lanes: Immunoprecipitation - Anti-Phosphotyrosine antibody [RM111] (ab190824)
The blot was was subjected twice to increasing exposure time in Lanes 3 and 4, and Lanes 5 and 6.
All lanes: Western blot - Anti-Phosphotyrosine antibody [RM111] (ab190824) at 1/5000 dilution
Lanes 1, 3 and 5: Non treated serum-starved A431 cell lysate
Lanes 2, 4 and 6: EGF treated serum-starved A431 cell lysate
Immunocytochemistry of serum-starved A431 cells nontreated (Left) or treated with EGF (Right) labeling Phosphotyrosine-EGFR using ab190824 at 1/500 dilution (followed by a PE conjugated secondary antibody, red) and DAPI (blue).
Analysis of ab190824 reaction to phosphorylated or nonphosphorylated Serine, Threonine, and Tyrosine. ab190824 only reacted to phosphorylated Tyrosine.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com